These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20350260)

  • 21. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
    Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged waiting times for liver transplantation in obese patients.
    Segev DL; Thompson RE; Locke JE; Simpkins CE; Thuluvath PJ; Montgomery RA; Maley WR
    Ann Surg; 2008 Nov; 248(5):863-70. PubMed ID: 18948816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.
    Croome KP; Lee DD; Burns JM; Keaveny AP; Taner CB
    Liver Transpl; 2018 Apr; 24(4):488-496. PubMed ID: 29365357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major adverse events, pretransplant assessment and outcome prediction.
    Huang HC; Lee FY; Huo TI
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1716-24. PubMed ID: 20136958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.
    Kremers WK; van IJperen M; Kim WR; Freeman RB; Harper AM; Kamath PS; Wiesner RH
    Hepatology; 2004 Mar; 39(3):764-9. PubMed ID: 14999695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The UNOS OPTN Waiting List and Donor Registry: 1988-1996.
    Harper AM; Rosendale JD
    Clin Transpl; 1996; ():69-90. PubMed ID: 9286559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Race and receipt of liver transplantation: location matters.
    Asrani SK; Kim WR; Kamath PS
    Liver Transpl; 2010 Sep; 16(9):1009-12. PubMed ID: 20818737
    [No Abstract]   [Full Text] [Related]  

  • 32. Geographic differences in access to transplantation in the United States.
    Ellison MD; Edwards LB; Edwards EB; Barker CF
    Transplantation; 2003 Nov; 76(9):1389-94. PubMed ID: 14627922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deceased donor kidney and liver transplantation to nonresident aliens in the United States.
    Schold JD; Meier-Kriesche HU; Duncan RP; Reed AI
    Transplantation; 2007 Dec; 84(12):1548-56. PubMed ID: 18165761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplant considerations for evaluation, CTP, and MELD.
    Mathews SB; Allison W; Lin S
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):403-11. PubMed ID: 20691390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential predictive value of the MELD score for short-term mortality after liver transplantation.
    Santori G; Andorno E; Antonucci A; Morelli N; Bottino G; Mondello R; Valente R; Panaro F; Ravazzoni F; Di Domenico S; Savelli A; Valente U
    Transplant Proc; 2004 Apr; 36(3):533-4. PubMed ID: 15110583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
    Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
    Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation.
    Foxton MR; Kendrick S; Sizer E; Muiesan P; Rela M; Wendon J; Heaton ND; O'Grady JG; Heneghan MA
    Transpl Int; 2006 Dec; 19(12):988-94. PubMed ID: 17081228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is waiting time a measure of access to liver transplantation? Is shorter necessarily better?
    Freeman RB
    Hepatology; 2007 Aug; 46(2):602-3. PubMed ID: 17661416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.